by Andrew Shaw | Jan 22, 2026 | Viewpoints
Professor Andrew Shaw, Founder & Chief Scientist, Attomarker Ltd The comment that stopped the conversation I have spent most of my career operating at the intersection of immunology, diagnostics, and clinical reality. I am comfortable with uncertainty, regulatory...